|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/29/19 Cytrx Corp 10-K 12/31/18 82:6M M2 Compliance/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 842K
2: EX-10.18 Material Contract HTML 73K
3: EX-23.1 Consent of Experts or Counsel HTML 25K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 29K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 29K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 26K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 25K
14: R1 Document and Entity Information HTML 61K
15: R2 Consolidated Balance Sheets HTML 105K
16: R3 Consolidated Balance Sheets (Parenthetical) HTML 50K
17: R4 Consolidated Statements of Operations HTML 86K
18: R5 Consolidated Statements of Stockholders' Equity HTML 90K
19: R6 Consolidated Statements of Cash Flows HTML 122K
20: R7 Nature of Business HTML 43K
21: R8 Summary of Significant Accounting Policies HTML 67K
22: R9 Discontinued Operations HTML 41K
23: R10 Foreign Currency Remeasurement HTML 27K
24: R11 Receivables HTML 31K
25: R12 Prepaid and Other Assets HTML 26K
26: R13 Equipment and Furnishings HTML 30K
27: R14 Accrued Expenses and Other Current Liabilities HTML 32K
28: R15 Deferred Revenues HTML 28K
29: R16 Term Loan HTML 35K
30: R17 Warrant Liabilities HTML 33K
31: R18 Commitments and Contingencies HTML 41K
32: R19 Equity Transactions HTML 30K
33: R20 Stock Options and Equity-Classified Warrants HTML 116K
34: R21 Stockholder Protection Rights Plan HTML 29K
35: R22 Income Taxes HTML 51K
36: R23 Schedule II - Valuation and Qualifying Accounts HTML 35K
37: R24 Summary of Significant Accounting Policies HTML 108K
(Policies)
38: R25 Summary of Significant Accounting Policies HTML 44K
(Tables)
39: R26 Discontinued Operations (Tables) HTML 44K
40: R27 Equipment and Furnishings (Tables) HTML 30K
41: R28 Accrued Expenses and Other Current Liabilities HTML 32K
(Tables)
42: R29 Term Loan (Tables) HTML 34K
43: R30 Warrant Liabilities (Tables) HTML 31K
44: R31 Commitments and Contingencies (Tables) HTML 36K
45: R32 Stock Options and Equity-Classified Warrants HTML 122K
(Tables)
46: R33 Income Taxes (Tables) HTML 48K
47: R34 Nature of Business (Details Narrative) HTML 64K
48: R35 Summary of Significant Accounting Policies HTML 44K
(Details Narrative)
49: R36 Summary of Significant Accounting Policies - HTML 34K
Schedule of Fair Value Measurements by Level for
Assets and Liabilities Measured at Fair Value on a
Recurring Basis (Details)
50: R37 Summary of Significant Accounting Policies - HTML 33K
Schedule of Changes in Carrying Amounts of Warrant
Liabilities (Details)
51: R38 Discontinued Operations (Details Narrative) HTML 32K
52: R39 Discontinued Operations - Schedule of Discontinued HTML 64K
Operations (Details)
53: R40 Foreign Currency Remeasurement (Details Narrative) HTML 28K
54: R41 Receivables (Details Narrative) HTML 32K
55: R42 Prepaid and Other Assets (Details Narrative) HTML 27K
56: R43 Equipment and Furnishings (Details Narrative) HTML 27K
57: R44 Equipment and Furnishings - Schedule of Equipment HTML 34K
and Furnishings (Details)
58: R45 Accrued Expenses and Other Current Liabilities - HTML 43K
Schedule of Accrued Expenses and Other Current
Liabilities (Details)
59: R46 Deferred Revenues (Details Narrative) HTML 28K
60: R47 Term Loan (Details Narrative) HTML 81K
61: R48 Term Loan - Schedule of Term Loan (Details) HTML 32K
62: R49 Warrant Liabilities (Details Narrative) HTML 37K
63: R50 Warrant Liabilities - Schedule of Weighted-average HTML 41K
Assumptions (Details)
64: R51 Commitments and Contingencies (Details Narrative) HTML 29K
65: R52 Commitments and Contingencies - Schedule of HTML 53K
Current Contractual Obligations (Details)
66: R53 Commitments and Contingencies - Schedule of HTML 28K
Current Contractual Obligations (Details)
(Parenthetical)
67: R54 Equity Transactions (Details Narrative) HTML 53K
68: R55 Stock Options and Equity-Classified Warrants HTML 100K
(Details Narrative)
69: R56 Stock Options and Equity-Classified Warrants - HTML 43K
Schedule of Share-based Payment Award, Fair Value
of the Stock Options Granted, Assumptions
(Details)
70: R57 Stock Options and Equity-Classified Warrants - HTML 71K
Schedule of Share-based Compensation, Stock
Options, Activity (Details)
71: R58 Stock Options and Equity-Classified Warrants - HTML 33K
Schedule of Total Stock-based Compensation Expense
from Stock Options (Details)
72: R59 Stock Options and Equity-Classified Warrants - HTML 54K
Schedule of Warrants Activity and Related
Information (Details)
73: R60 Stock Options and Equity-Classified Warrants - HTML 63K
Schedule of Ranges of Stock Options (Details)
74: R61 Stock Options and Equity-Classified Warrants - HTML 62K
Schedule of Ranges of Warrants (Details)
75: R62 Stockholder Protection Rights Plan (Details HTML 32K
Narrative)
76: R63 Income Taxes (Details Narrative) HTML 47K
77: R64 Income Taxes - Schedule of Deferred Tax Assets and HTML 46K
Liabilities (Details)
78: R65 Income Taxes - Schedule of Effective Income Tax HTML 57K
Rate Reconciliation (Details)
79: R66 Schedule II - Valuation and Qualifying Accounts HTML 33K
(Details)
81: XML IDEA XML File -- Filing Summary XML 147K
80: EXCEL IDEA Workbook of Financial Reports XLSX 78K
8: EX-101.INS XBRL Instance -- cytr-20181231 XML 1.31M
10: EX-101.CAL XBRL Calculations -- cytr-20181231_cal XML 171K
11: EX-101.DEF XBRL Definitions -- cytr-20181231_def XML 616K
12: EX-101.LAB XBRL Labels -- cytr-20181231_lab XML 1.03M
13: EX-101.PRE XBRL Presentations -- cytr-20181231_pre XML 821K
9: EX-101.SCH XBRL Schema -- cytr-20181231 XSD 180K
82: ZIP XBRL Zipped Folder -- 0001493152-19-004165-xbrl Zip 138K
Exhibit 32.1
Certification of Chief Executive Officer
Pursuant to 18 U.S.C. 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of CytRx Corporation (the “Company”) hereby certifies that:
(i) the accompanying Annual Report on Form 10-K of the Company for the year ended December 31, 2018 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: March 29, 2019 | By: | /s/ STEVEN A. KRIEGSMAN |
| Steven A. Kriegsman | ||
| Chairman and Chief Executive Officer |
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 (Section 906), or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to CytRx Corporation and will be retained by CytRx Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished to the Securities and Exchange Commission as an Exhibit to the Form 10-K and shall not be considered filed as part of the Form 10-K.
C:
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/29/19 | None on these Dates | ||
| For Period end: | 12/31/18 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/14/23 LadRx Corp. S-1 66:6M M2 Compliance LLC/FA 3/20/23 LadRx Corp. 10-K 12/31/22 72:6.2M M2 Compliance LLC/FA 3/23/22 LadRx Corp. S-1/A 3:458K M2 Compliance LLC/FA 3/23/22 LadRx Corp. 10-K 12/31/21 72:5.8M M2 Compliance LLC/FA 8/04/21 LadRx Corp. S-1 3:453K M2 Compliance LLC/FA 7/13/21 LadRx Corp. 10-K/A 12/31/20 4:270K M2 Compliance LLC/FA 3/24/21 LadRx Corp. 10-K 12/31/20 68:8.1M M2 Compliance LLC/FA |